drugset / Trial / NCT04752020
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
NaSingle-groupOpen-labelTreatment
Summary
This will be a prospective assessment of whether adjuvant Netarsudil use in patients undergoing Descemetorhexis without endothelial keratoplasty improves time to corneal clearance and post-operative central endothelial cell counts. The anticipated enrollment is 25 patients.
Timeline
- Start
- 2021-03-28
- Primary completion
- 2023-06-28
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Netarsudil | Small molecule | — | Topical |